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The purpose of this study is to examine the value of one or two simple verbal questions in the detection of depression in cancer
settings. This study is a systematic literature search of abstract and full text databases to January 2008. Key authors were contacted for
unpublished studies. Seventeen analyses were found. Of these, 13 were conducted in late stage palliative settings. (1) Single
depression question: across nine studies, the prevalence of depression was 16%. A single ‘depression’ question enabled the detection
of depression in 160 out of 223 true cases, a sensitivity of 72%, and correctly reassured 964 out of 1166 non-depressed cancer
sufferers, a specificity of 83%. The positive predictive value (PPV) was 44% and the negative predictive value (NPV) 94%. (2) Single
interest question: there were only three studies examining the ‘loss-of-interest’ question, with a combined prevalence of 14%. This
question allowed the detection of 60 out of 72 cases (sensitivity 83%) and excluded 394 from 459 non-depressed cases (specificity of
86%). The PPV was 48% and the NPV 97%. (3) Two questions (low mood and low interest): five studies examined two questions
with a combined prevalence of 17%. The two-question combination facilitated a diagnosis of depression in 138 of 151 true cases
(sensitivity 91%) and gave correct reassurance to 645 of 749 non-cases (specificity 86%). The PPV was 57% and the NPV 98%. Simple
verbal methods perform well at excluding depression in the non-depressed but perform poorly at confirming depression. The ‘two
question’ method is significantly more accurate than either single question but clinicians should not rely on these simple questions
alone and should be prepared to assess the patient more thoroughly.
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There is a general consensus that it is important to recognise and
treat depression during the course of cancer, especially in palliative
stages where particular emphasis is on quality of life (Stiefel et al,
2001; Noorani and Montagnini, 2007). Distress, anxiety and
depression powerfully influence quality of life as well as
satisfaction with care and participation in medical treatment
(Skarstein et al, 2000; Stark et al, 2002; Kennard et al, 2004; Bui
et al, 2005). Studies that have used structured psychiatric
interviews suggest that the median prevalence of major depressive
disorder is 15% in advanced cancer (Hotopf et al, 2002). Four
large-scale studies using severity scales suggest that the overall
prevalence of distress in unselected cancer patients is above 30%
(Pascoe et al, 2000; Fallowfield et al, 2001; Zabora et al, 2001;
Carlson et al, 2004). Yet, it is well known that syndromal anxiety
and depression are often overlooked by busy cancer professionals
in palliative and non-palliative settings (Ford et al, 1994;
Fallowfield et al, 2001; Sollner et al, 2001; Stiefel et al, 2001;
Durkin et al, 2003; Sharpe et al, 2004) and the majority of patients
will not gain access to mental health services (Kadan-Lottick et al,
2005). In part, this is because cancer specialists have difficulty in
identifying emotional complications and tend to have commu-
nication behaviours that systematically focus on physical rather
than psychological concerns (Durkin et al, 2003).
More than 50 questionnaires have been developed to aid the
detection of depression or severe distress, but most have been
validated in primary care rather than cancer settings (Lloyd-
Williams et al, 2003b). Perhaps, best known of all depression scales
is the Patient Health Questionnaire (in either nine or two item
forms) (Spitzer et al, 1999). This scale has some merit in primary
care and appears highly acceptable (Mitchell and Coyne, 2007) but
has yet to be rigorously tested in cancer settings. Indeed, only a
handful of tools have been studied specifically in palliative care (Le
Fevre et al, 1999; Holtom and Barraclough, 2000; Lloyd-Williams
et al, 2001, 2004; Love et al, 2004; Thekkumpurath et al, 2007).
Their main limitation, however, is that they are often too long for
routine use (Mitchell et al, 2008). In response to this problem,
short versions of many common depression scales have been
developed. These include 7 and 6 item versions of the Hamilton
Depression Rating Scale (HAMD) (McIntyre et al, 2005; Guo et al,
2006; Serrano-Duen and Soledad, 2007); 13, 7 and 2 item versions
of the Beck Depression Inventory (BDI) (Steer et al, 1999;
Furlanetto et al, 2005; Huffman et al 2006); 13, 10 and 6 item
versions of the Center for Epidemiologic Studies Depression Scale
(CES-D) (Burnam et al, 1988; Cole et al, 2004; Covic et al, 2007); 5,
4 and 2 item versions of the Geriatric Depression Scale (GDS)
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s(Andresen et al, 1994; van Marwijk et al, 1995; Hoyl et al, 1999);
and 8, 6 and 5 item versions of the Edinburgh Depression
scale (EPDS) (Pallant et al, 2006; Eberhard-Gran et al, 2007;
Lloyd-Williams et al, 2007). Occasionally, authors have developed
entirely new short scales, such as the four item case-find for
depression (Jefford et al, 2004), or attempted to develop a short
scale specifically for palliative settings (Lloyd-Williams et al, 2007).
In the 1990s, several groups working in cancer settings
suggested that two questions, or in some cases just a single
question, might be sufficient to detect depression in palliative
care. Usually, these ultra-short tests formed part of symptom
checklists and were not validated against an accepted standard
(Miller and Walsh, 1991; Donnelly et al, 1995; Conill et al, 1997;
Brunelli et al, 1998; Edmonds et al, 1998; Ng and von Gunten, 1998;
Pratheepawanit et al, 1999). At the same time, simple (non-verbal)
visual-analogue methods of assessing depression, anxiety or
distress were developed, exemplified by the NCCN Distress
Thermometer and Edmonton Symptom Assessment (Hu ¨rny et al,
1996; Vignaroli et al, 2006). The accuracy of these methods was
reviewed in mixed cancer settings with the finding that they had
reasonable rule-out accuracy but limited case-finding ability
(Mitchell, 2007). Yet, it is not clear how simple verbal questions
perform alone and when used specifically for patients with
advanced cancer.
The aim of this study is to examine the diagnostic accuracy of
simple verbal questions to detect depression in cancer and
palliative care and to ascertain whether clinicians should rely
upon either one question or two questions to detect major
depression compared with more established screening tools.
MATERIALS AND METHODS
Search
A systematic literature search, critical appraisal of the collected
studies and pooled analysis were conducted. The following abstract
databases were searched: Medline 1966-January 2008, PsycINFO
1887-January 2008, Embase 1980-January 2008 and CINAHL 1982-
January 2008. In these databases, the keywords (MeSH terms) were
‘distress or anxi$ or depress$ or mood’ and ‘screen$ or detect$ or
case-finding or recogni$ or diagnos$ or recogni$’ and ‘cancer or
oncology or malignant or transplant or tumour or metastatic.’
Four full text collections including Science Direct, Ingenta Select,
Ovid Full text and Wiley Interscience were searched. In these
online databases, the same search terms were used but as a full text
search and citation search. The abstract database Web of Knowl-
edge (4.0, ISI) was searched, using the above terms as a text word
search, and using key papers in a reverse citation search.
Conference abstracts from IPOS 2006 and 2007 were examined.
Non-English language papers and abstracts were included but,
where necessary, authors were contacted directly for primary data
and data in press.
Critical appraisal
The review guidelines for diagnostic tests recently outlined in
Evidence Based Medicine were followed (Pai et al, 2004). Questions
for each report included the setting, the data integrity, the choice
of reference criterion, the method of application of the screening
questionnaire and, importantly, the type of outcome measured.
Quality appraisal standards are listed in Table 1.
Pooled analysis and meta-analysis
Two methods are possible in combining diagnostic validity studies
(Midgette et al, 1993; Irwig et al, 1995). (a) Simple pooling of the
raw data and re-calculation of the cumulative sensitivity,
specificity, positive predictive value (PPV) and negative predictive
value (NPV). This method assumes a consistent prevalence
between studies and in future work. (b) Correction for the
variance in prevalence by relying on the stability of sensitivity and
specificity by calculating a pooled weighted rate of sensitivity and
specificity and then calculating PPV and NPV according to local
prevalence data (Glasziou and Irwig, 1998). In this case, a Bayesian
curve can be constructed of all post-test probabilities if a given test
is positive or negative. Overall accuracy was calculated using the
identificiation index which is the fraction correct minus faction
incorrect. The reciprocal of the identification index is the number
needed to screen (Mitchell, 2009).
Standards of accuracy
Performance was taken as follows: o0.2 poor, 40.2p0.4 fair,
40.4p0.6 moderate, 40.6p0.8 good and 40.8p1 very good;
adapted from that originally proposed by Landis and Koch (Landis
and Koch, 1977).
Outcome measures
The majority of studies defined depression using a psychiatric
interview (applied in a semistructured or clinical interview) but a
minority utilised standardised rating scales (Murphy, 2002).
RESULTS
Systematic literature search
The search identified 98 analyses specifically examining ultra-short
methods (Figure 1). Studies that examined one or two question
methods in non-cancer medical patients or in primary care were
excluded. A total of 39 studies had no gold standard and 29
examined visual-analogue methods and were therefore excluded.
Thirteen studies were not sufficiently detailed for inclusion. Thus,
17 analyses of verbal/written questions to detect depression in
cancer were included. No attempt was made to separate questions
read by investigators (verbal) from questions read by the patients
(written). The data extraction is illustrated in Figure 1 in
accordance with Quality of Reporting of Meta-analyses guidelines
(Moher et al, 1999).
Of 17 analyses, 9 examined one single depression question:
Chochinov et al (1997); Lloyd-Williams et al (2003a); Meyer et al
(2003a); Jefford et al (2004); Akechi et al (2006); Kawase et al
(2006); Ohno et al (2006); Payne et al (2007); and Mitchell et al
(2008). Three analyses examined one single interest item: Akechi
et al (2006); Payne et al (2007); and Mitchell et al (2008). Five
analyses examined a combination of two questions: Akechi et al
(2006); 65 Payne et al (2007); Chochinov et al (1997); Gessler et al
(2007); and Mitchell et al (2008).
Critical appraisal
The mean sample size was 165.8 (s.d. 55.7). However, several
studies examined different verbal methods in the same sample and
thus there were actually 1579 unique patients under study. Eleven
studies took place in palliative settings and/or specifically in those
with late-stage cancer. Three took place in mixed stages and three
in predominantly early cancers. All but two studies used DSM
criteria by clinical interview or by structured clinical interview.
Four looked at major or minor depression combined and the
remainder looked at major depression alone.
The most common question for depression was simply ‘Are you
depressed?’ but variations included ‘Describe your mood over the
last week’ and the PHQ2 question two ‘Over the last 2 weeks, how
often have you been bothered by feeling down, depressed or
hopeless?’ The loss of interest question was asked in three different
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of interest in things or activities that you would normally enjoy?’
and the PHQ2 question one ‘Over the last 2 weeks, how often have
you been bothered by little interest or pleasure in doing things?’
The two-question approach was always asked as question 1 (Q1) or
question 2 (Q2), which favours sensitivity at the expense of
specificity compared to the Q1 and Q2 approach (Coyne
and Mitchell, 2007). Further details of the studies are shown in
Tables 1 and 2.
Pooled analysis and meta-analysis
Single depression/mood question Across nine studies, the pre-
valence of depression was 16%. Using the simple pooled method,
the single depression question enabled the detection of depression
in 160 out of 223 true cases, a sensitivity of 72% (95% CI
66.3–76.8%) and correctly reassured 964 out of 1166 non-
depressed cancer sufferers, a specificity of 83% (95% CI 81.6–
83.6). Thus, the PPV was 44% and the NPV was 94%. The Youden
score was 0.544 (95% CI 47.9–60.3). Using the meta-analytic
approach, the weighted sensitivity was 74.1% (95% CI¼0.68–0.80)
and the specificity was 85.8% (95% CI 83.7–87.7).
Analysing the results by natural frequencies, out of every 100
screening applications, the single depression question would
correctly rule out 69 non-depressed, rule in 11 out of 18 cases,
missing 5 and also giving 15 false-positive diagnoses (Figure 2).
Thus, the identification index (net gain) would be 61.8% and the
number needed to screen in order to yield one additional correct
identification would be 1.62.
Single interest question There were only three studies examining
the ‘loss-of-interest’ question, with a pooled prevalence of 14%.
Using the simple pooled method, this question allowed
the detection of 60 out of 72 cases (sensitivity 83%) (95% CI
74.2–89.9) and excluded 394 from 459 non-depressed cases
(specificity of 86%) (95% CI 84.4–89.9). The PPV was 48% and
the NPV 97%. The Youden score was 0.692 (95% CI 0.586–0.768).
Using the meta-analytic approach, the weighted sensitivity was
82.4% (95% CI¼73.0–90.0) and the specificity was 86.4 (95%
CI¼83.0–89.3).
Analysing the results by natural frequencies, out of every 100
screening applications, the single loss of interest question would
correctly rule out 74 non-depressed, rule in 11 out of 14 cases,
missing 2 and also giving 12 false-positive diagnoses (Figure 2).
Thus, the identification index (net gain) would be 71% and the
number needed to screen in order to yield one additional correct
identification would be 1.41.
Two questions (low mood and low interest) In five studies using a
two-question combination (Q1 or Q2), the prevalence of depres-
sion was 17%. Using the simple pooled method, the two-question
combination facilitated a diagnosis of depression in 138 of 151 true
cases (sensitivity 91.4%) (95% CI 86.4–94.8) and gave correct
reassurance to 645 of 749 non-cases (specificity 86%) (95% CI
85.1–86.8). The PPV was 57% and the NPV 98%. The Youden
score was 0.775 (95% CI 0.771–0.816), significantly higher than
either of the single questions used alone. Using the meta-analytic
approach, the weighted sensitivity was 92.7% (95% CI¼88.1–96.3)
and specificity 87.4% (95% CI¼84.9–89.7).
HADS-total score (n=2)
Early stage (n=3)
Mixed stage (n=3)
No diagnostic validity testing 
(n=39)
Simple verbal question
diagnostic accuracy studies
(n=17)
Single depression
question (n=9)
DSM major and minor 
depression (n=4)
Excluded long, medium,
short tests (n=122)
Non-validated comparison
(n=1)
Insufficient data available
(n=4)
Non-cancer settings
(n=6)
Excluded primary care 
studies (n=32)
Non-STARD compliant
(n=2)
Single interest question
(n=3)
Two questions (n=5)
Palliative care (n=11)
DSM major depression
(n=11)
ICD10 depression (n=0)
Examined ultra-short tests
(n=98)
Verbal and non-verbal
Studies (n=59)
Primary data reports
(n=258)
Non-verbal methods 
(n=29)
Outcome measure Ultra-short method Setting/sample
Figure 1 Quorom diagram of studies.
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sTable 1 Methodological aspects of simple verbal questions for depression in cancer
Year Author Screening question Reference Standard
Sample used for
diagnostic testing
(u) Setting Comment Quality appraisal
1997 Chochinov
et al, 1997
‘Are you depressed?’
‘Are you depressed OR
have you lost interest?
RDC Mj+Mn Dep 197 Palliative Sample was 94 male and 103 female
inpatients receiving palliative care for
advanced terminal cancer. Enhanced
reliability was attempted by having an
observer (a psychiatrist or psychologist)
attend a random sample of 27 interviews.
Chochinov et al examined whether the first
two questions of the diagnostic interview
could be used on their own when used at the
same time as the clinical interview. The lack
of administration of a blind independent
criterion standard may partly explain the
high accuracy of this method alone.
Sample–Adequate
Blinding–Poor
Gold Standard–
Adequate
Sample integrity–
Adequate
2003 Lloyd-Williams
et al, 2003a
‘Are you depressed?’ Clinical interview based
on DSMIV
74 Palliative Recruited those in palliative and supportive
day care over 6 months. Gold standard was
the semi-structured clinical psychiatric
interview based on DSMIV, although the
exact method of administration was not
disclosed.
Sample–Poor
Blinding–Adequate
Gold Standard–
Adequate
Sample integrity–Good
2006 Akechi et al,
2006
‘Are you depressed?’
‘Have you lost interest?’
1. Structured clinical
interview for DSM-III-
R.Mj Dep
2. Structured clinical
interview for DSM-III-
R.Mj Dep+ adjustment
205 Palliative The reliability (kappa coefficient) of the
interview ratings was investigated by having
another trained psychiatrist attend the first
29 consecutive interviews as a second rater.
Mean age was 61 years; 137 (66%) subjects
were male and 51 (24%) were in full-time
employment. The most frequent primary
cancer site was the lung (38%). In head-to-
head analysis the single-item interview
‘Have you lost interest or pleasure?’ (AUC
0.92) performed better than ‘Are you
depressed?’ (AUC 0.85) or indeed the
HADS-D arm (AUC¼0.82) or the HADS-
Total score (AUC¼0.79).
Sample–Adequate
Blinding–Adequate
Gold Standard–Good
Sample integrity–
Adequate
2006 Kawase et al,
2006
‘Are you depressed?’ DSM-IV-TR MjþMn
Dep
282 Mixed Cancer
Outpatients undergoing
radiotherapy
Sample aged 26–90 years (mean 62.2).
Interview by clinical psychologists with
100% concordance. Major and minor
depression not separated in the analysis.
Sample–Good
Blinding–Adequate
Gold Standard–
Adequate
Sample integrity–
Adequate
2007 Payne et al
(2007)
‘Are you depressed?’
OR
‘Have you experienced
loss of interest in things
or activities that you
would normally enjoy?’
Clinical interview based
on DSMIV major
depressive disorder as
defined by DSM
conducted by one of
two mental health
professionals
167 (74% were
suffering from cancer)
Inpatient Palliative Unit A subgroup analysis of individuals with a
past experience of depressive illness, (n 95)
revealed that a significant number screened
positive for depression by the screening
test, 55.2% (16/29) compared with those
with no background history of depression,
33.3% (22/66) (P¼0.045).
Sample–Adequate
Blinding–Adequate
Gold Standard–
Adequate
Sample integrity–
Adequate
2004 Jefford et al,
2004
‘Over the past couple
of weeks, have you
been feeling unhappy
or depressed?’
PRIME-MD (DSMIV)
but validation based on
the 4Q Brief Case-Find
for Depression (BCD)
100 Late (60% palliative) Also used Prime-MD, BDI and HADS.
Patients with depression had more pain and
inferior performance status/functioning.
Authors suggest that the BCD can be
administered in 1min in oncology and
palliative settings.
Sample–Poor
Blinding–Poor
Gold Standard–Poor
Sample integrity–
Adequate
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Clinical StudiesTable 1 (Continued)
Year Author Screening question Reference Standard
Sample used for
diagnostic testing
(u) Setting Comment Quality appraisal
2006 Ohno et al,
2006
‘Are you depressed or
not?’
HADS Combined 414 160 Mixed Cancers Assessed diagnostic accuracy of patients
who refused to answer Q ‘are you
depressed’
Sample–Adequate
Blinding–Poor
Gold Standard–Poor
Sample integrity–
Adequate
2003 Meyer et al,
2003
Schedule of affective
disorders and
schizophrenia (SADS)
item: please describe
your mood over the
past week(s) (or since
last seen) in terms of
low mood or
depression (not at all,
slight vs mild, moderate
or severe).
Structured clinical
interview for DSM-III-R
(SCID), a semi-
structured interview for
diagnosing depression
45 Inpatients with
advanced cancer
(prognosis B/6 months)
consecutively referred
to a hospital palliative
care team
Authors compared mood evaluation
questionnaire (MEQ) and the structured
clinical interview for DSM-III-R (SCID) as
well as the single-item interview screening
question. The MEQ and SCID had
moderate agreement (weighted kappa 0.52
over all interviews). At first interview, 26
(58%) patients were depressed using MEQ,
seven (16%) of these severely.
Sample–Poor
Blinding–Adequate
Gold Standard–Good
Sample integrity–
Adequate
2007 Gessler et al,
2007 (online
published)
2Q‘Have you lost
interest or pleasure?’
OR
‘Are you depressed?’
HADS combined 411 160 Mixed outpatients with
cancer
53% female and mean age 60.0 years. Also
tested were the HADS, GHQ-12, BSI-18
and DT.
Sample–Adequate
Blinding–Poor
Gold Standard–Poor
Sample integrity–
Adequate
2008 Baker-Glenn,
Thiagarajan;
Chaudhuri,
Granger,
Symonds,
Mitchell, 2008
(unpublished)
PHQ Q1 – ‘Over the
last 2 weeks, how often
have you been
bothered by little
interest or pleasure in
doing things?’
PHQ Q2 ‘Over the last
2 weeks, how often
have you been
bothered by feeling
down, depressed or
hopeless?’
DSMIV major
depression
215 Cancer patients
attending
chemotherapy
Mean age was 57.7 years and their mean
time from diagnosis 7.3 months. The
prevalence of major depressions was
11.1%. Patients also received the HADS,
PHQ9 and DT.
Sample–Adequate
Blinding–Poor
Gold Standard–
Adequate
Sample integrity–
Adequate
(u)¼Uncorrected; 1Q¼single question test, 2Q¼two question test; RDC¼research diagnostic criteria; HADS¼Hospital Anxiety and Depression Scale; CESD¼Center for Epidemiologic Studies Depression Scale (CES-D);
BCD¼Brief Case Find for Depression includes the items ‘(A) been having restless or disturbed nights? (B) been feeling unhappy or depressed? (C) felt unable to overcome your difficulties? (D) been dissatisfied with the way you’ve
been doing things.’ Quality appraisal: Sample o100¼poor; o250¼adequate; o500¼good; 4499¼excellent; Blinding – both scale and gold standard by same rater¼poor; different rater¼adequate; different rate blind to
results¼good; Gold Standard–Depression severity scale¼poor; DSM or ICD10 criteria¼adequate; semi-structured or structured interview¼good; sample integrity – unexplained missing data – poor; partial loss to follow-
up¼adequate; no missing data¼good. Dep¼Depression; PHQ¼Patient Health Questionnaire; Mj¼Major; Mn¼Minor.
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sTable 2 Statistical summary of simple verbal questions for depression in cancer
Reference Assessment of depression
Total cases
with
depression Sensitivity
Total cases
without
depression Specificity PPV NPV
Youden
score
Number
needed to
screen
a
Depression question
Akechi et al, 2006 1Q – ‘Are you depressed?’ 14 0.79 195 0.92 0.41 0.98 0.70 1.22
Payne et al, 2007 1Q – ‘Are you depressed?’ 43 0.70 124 0.81 0.57 0.89 0.51 1.76
Chochinov et al, 1997 1Q – ‘Are you depressed?’ 24 1.00 173 1.00 1.00 1.00 1.00 1.00
Lloyd-Williams et al, 2003a 1Q – ‘Are you depressed?’ 20 0.55 54 0.74 0.44 0.82 0.29 2.64
Jefford et al, 2004 1Q – Over the past couple of weeks, have you
been feeling unhappy or depressed?
12 0.67 88 0.70 0.24 0.94 0.37 2.50
Ohno et al, 2006 1Q – ‘Are you depressed or not?’ 54 0.93 106 0.31 0.41 0.89 0.24 26.67
Meyer et al, 2003 1Q – ‘Describe your mood over the last week’ 17 0.35 28 0.75 0.46 0.66 0.10 5.00
Baker-Glenn, Thiagarajan; Chaudhuri,
Granger, Symonds, Mitchell, 2008
(unpublished)
1Q – ‘Over the last 2 weeks, how often have you been
bothered by feeling down depressed or hopeless?’
15 0.67 140 0.95 0.59 0.96 0.62 1.18
Kawase et al, 2006 1Q – ‘Are you depressed?’ 24 0.42 258 0.86 0.22 0.94 0.28 1.55
Pooled summary Subtotal – depressed 223 0.72 1166 0.83 0.44 0.94 0.54 1.62
Interest question
Payne et al, 2007 1Q – ‘Have you experienced loss of interest in things or
activities that you would normally enjoy?’
43 0.79 124 0.73 0.50 0.91 0.52 2.06
Baker-Glenn, Thiagarajan; Chaudhuri,
Granger, Symonds, Mitchell, 2008
(unpublished)
1Q – Over the last 2 weeks, how often have you been
bothered by little interest or pleasure in doing things?’
15 0.87 140 0.89 0.46 0.98 0.76 1.28
Akechi et al, 2006 1Q – ‘Have you lost interest?’ 14 0.93 195 0.92 0.45 0.99 0.85 1.19
Pooled summary Subtotal – interest 72 0.83 459 0.86 0.48 0.97 0.69 1.41
Combination question
Payne et al, 2007 2Q – ‘Depressed or loss of interest’ 43 0.91 124 0.68 0.49 0.95 0.58 2.11
Akechi et al, 2006 2Q – ‘Have you lost interest or pleasure?’ OR ‘Are you
depressed?’
14 1.00 195 0.86 0.34 1.00 0.86 1.35
Baker-Glenn, Thiagarajan; Chaudhuri,
Granger, Symonds, Mitchell, 2007
(online published)
2Q – PHQ1 or 2 15 1.00 140 0.87 0.45 1.00 0.87 1.30
Gessler et al, 2007
(online published)
2Q – ‘Have you lost interest or pleasure?’ OR ‘Are you
depressed?’
43 0.79 117 0.86 0.68 0.92 0.65 1.45
Chochinov et al (1997) 2Q – Depressed mood OR loss of interest 36 1.00 173 0.98 0.92 1.00 0.98 1.03
Pooled summary Subtotal – 2Q 151 0.91 749 0.86 0.57 0.98 0.78 1.35
PPV¼positive predictive value; NPV¼negative predictive value. 1Q¼Single question; 2Q¼Two question combination.
aNumber needed to screen¼reciprocal of fraction correct minus faction incorrect.
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Clinical StudiesAnalysing the results by natural frequencies, out of every 100
screening applications, these two questions would correctly rule
out 72 non-depressed, rule in 15 out of 18 cases, overlooking 1 true
case and also giving 12 false-positive diagnoses (Figure 2). Thus,
the identification index (net gain) would be 74% and the number
needed to screen in order to yield one additional correct
identification would be 1.35.
Bayesian pre-test–post-test gain Assuming sensitivity and speci-
ficity hold for different rates of depression, a Bayesian curve was
constructed of all post-test probabilities where a test result was
either positive or negative. This illustrates the pre-test–post-test
gain for each method and the predictive value conditional upon
different baseline rates of depression. Figure 3 demonstrated the
superior difference in gain for the two-question approach with the
depression question alone.
CONCLUSIONS
A previous pooled analysis found eight diagnostic validity analyses
of one or two single item questions in the detection of depression
in cancer settings (Mitchell, 2007). This study updates the previous
analysis to include 17 analyses, 13 involving late-stage cancer and/
or palliative settings. It is important to note that the average
prevalence of depression across these studies was 16% (range 7–
38%), which means that any case-finding method is likely to have
difficulty detecting true cases without generating false positives.
Results show that the loss of interest question is somewhat better
than the depression question when used alone. This corresponds
to research showing that, of many symptoms of depression, loss of
interest best discriminated between patients with and without
diagnosis of comorbid affective disorder (Reuter et al, 2004).
However, two questions are significantly better than any one
1.7%
2.7%
4.7%
16.5%
13.0%
70.2%
71.5%
66.7%
11.5%
13.3%
15.7%
12.5%
0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 40.0 45.0 50.0 55.0 60.0 65.0 70.0 75.0 80.0 85.0 90.0 95.0 100.0
Depression and
 interest Q
Interest question
Depression question
False negatives (%)
Correctly diagnosed (%)
Correct reassured (%)
False positives (%)
Depressed Non-depressed
Depressed
Depressed
c
Non-depressed
Non-depressed
Figure 2 Natural screening accuracy of simple verbal questions in the detection of cancer-related depression.
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questions, 0.54 for the depression question and 0.69 for the interest
question). In fact, two questions are better for both ruling in and
ruling out a diagnosis than either question alone, although the loss
of interest question is also an excellent method of excluding
depression. No method achieved a case-finding accuracy of more
than 60% according to the PPVs. This means that at best there
would be 43 false positives out of each 100 positive screens.
There has been increasing interest in short verbal and non-
verbal screening methods. Lloyd-Williams and colleagues (Lawrie
et al, 2004) found that among consultants working in palliative
medicine, 10% asked the patient ‘are you depressed’ to detect
depression. Mitchell et al (2008) and colleagues found that simple
verbal questions were the most preferred active method of
detecting depression, used by 30% of cancer professionals.
However, this meta-analysis raises an important caution for all
those using one or two questions. Assuming use of the two-
question combination, this would mean that out of every 100
screening applications answering yes to either of these two
questions, only 1 true case would be missed but 12 false-positive
diagnoses would be generated (Figure 2). Thus, a second method
with better PPV would be required. This could be a thorough
clinical assessment by someone confidently able to diagnose
depression or it could be a longer validated depression severity
scale (Robinson and Crawford, 2005). However, there is no
agreement on which is the optimal case-finding method and
rarely has any method shown a case-finding (PPV) accuracy that
exceeds 0.80. (Lloyd-Williams et al, 2003b; Trask, 2004). There is
also no agreement on how often a tool should be applied (Lloyd-
Williams and Riddleston, 2002). For example, Love et al (2004)
found that the HADS depression subscale had a PPV of 0.79 when
a cut-off of 7v8 was used. Using the same cut-off, Le Fevre et al
(1999) found a PPV of 0.42 in a palliative settings. Recently, Lloyd-
Williams et al (2007) showed that a six-item adaptation of the
EPDS had a PPV of 0.65, also in a palliative setting.
In conclusion, no method has been shown to be sufficiently
accurate to be considered the definitive screening or case-finding
tool for cancer-related depression. Simple questions should be
considered as a method of exclusion or combined with more
detailed tests. Future work should move beyond screening for
psychopathology alone to also consider unmet needs. That is,
those individuals with emotional disorders (distress, anxiety,
depression and anger) who require and desire professional help
(Graves et al, 2007).
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